Medicare Enrolled
Dr. Nicolas Saikali, MD
Neurology · Amherst, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Saikali from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Saikali?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Saikali
Dr. Nicolas Saikali is a neurology specialist in Amherst, NY, with 17 years of NPI registration. Based on federal Medicare data, Dr. Saikali performed 11,117 Medicare services across 215 unique beneficiaries.
Between the years covered by Open Payments, Dr. Saikali received a total of $1,545,186 from 97 pharmaceutical and/or device companies across 3557 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Saikali is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 8% volume in NY
$1,545,186 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,117
Medicare services
Top 8% in NY for neurology
215
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~654 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
10,800 | $5 | $10 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
54 | $112 | $325 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
44 | $0 | $6 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
34 | $100 | $220 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
31 | $11 | $34 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
31 | $112 | $225 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
30 | $46 | $125 |
| Injection of anesthetic or steroid into upper neck and back of head nerve An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head. |
29 | $20 | $317 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 29 | $45 | $317 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
23 | $61 | $100 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
12 | $79 | $165 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.0% high complexity
98.4% medium
0.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,545,186
Total received (2018-2024)
Avg $220,741/year across 7 years
Top 0% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
97
Companies
3,557
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,447,387 (93.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$80,606 (5.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,193 (1.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$192,491
2023
$177,506
2022
$234,306
2021
$324,947
2020
$265,580
2019
$171,899
2018
$178,457
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$145,279
Lundbeck LLC
$29,327
Teva Pharmaceuticals USA, Inc.
$8,442
Axsome Therapeutics, Inc.
$4,380
H. Lundbeck A S
$1,213
MDD US Operations, LLC
$850
Tonix Medicines, Inc.
$775
UCB, Inc.
$438
PFIZER INC.
$427
Lilly USA, LLC
$288
SCILEX PHARMACEUTICALS INC.
$264
Alexion Pharmaceuticals, Inc.
$129
Eisai Inc.
$82
Biogen, Inc.
$67
TG Therapeutics, Inc.
$60
Azurity Pharmaceuticals, Inc.
$55
Amgen Inc.
$51
Currax Pharmaceuticals LLC
$48
LivaNova USA, Inc.
$46
Neurocrine Biosciences, Inc.
$37
JAZZ PHARMACEUTICALS INC.
$34
ARGENX US, INC.
$32
Takeda Pharmaceuticals U.S.A., Inc.
$30
Merck Sharp & Dohme LLC
$24
Mirum Pharmaceuticals, Inc.
$22
MITSUBISHI TANABE PHARMA AMERICA, INC.
$20
CATALYST PHARMACEUTICALS, INC.
$19
Grifols USA, LLC
$19
Novo Nordisk Inc
$18
IBSA Pharma Inc.
$17
Top 3 companies account for 95.1% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$277,287
AbbVie Inc.
$238,702
ABBVIE INC.
$237,981
Allergan, Inc.
$199,177
Biohaven Pharmaceuticals, Inc.
$110,471
Lundbeck LLC
$102,364
Teva Pharmaceuticals USA, Inc.
$97,759
Allergan Inc.
$73,840
Biohaven Pharmaceutical Holding Company Ltd.
$56,748
IMPEL PHARMACEUTICALS INC.
$43,708
Avanir Pharmaceuticals, Inc.
$21,800
Promius Pharma LLC
$19,755
Lilly USA, LLC
$14,935
Assertio Therapeutics, Inc.
$14,896
Supernus Pharmaceuticals, Inc.
$10,825
Axsome Therapeutics, Inc.
$4,380
Egalet US Inc
$2,107
TONIX PHARMACEUTICALS, INC.
$2,000
LivaNova USA, Inc.
$1,799
UPSHER-SMITH LABORATORIES LLC
$1,788
H. Lundbeck A S
$1,213
Novartis Pharmaceuticals Corporation
$1,188
UCB, Inc.
$1,170
MDD US Operations, LLC
$1,031
PFIZER INC.
$873
Tonix Medicines, Inc.
$775
SK Life Science, Inc.
$363
ASSERTIO THERAPEUTICS, Inc.
$335
Zyla Life Sciences
$320
Alexion Pharmaceuticals, Inc.
$281
SCILEX PHARMACEUTICALS INC.
$264
Upsher-Smith Laboratories LLC
$261
Eisai Inc.
$254
Biogen, Inc.
$245
GE HEALTHCARE
$223
ARBOR PHARMACEUTICALS, INC.
$216
Currax Pharmaceuticals LLC
$214
Neurocrine Biosciences, Inc.
$208
Kestra Medical Technology Services, Inc.
$187
Azurity Pharmaceuticals, Inc.
$184
ACADIA Pharmaceuticals Inc
$160
Collegium Pharmaceutical, Inc.
$151
Eli Lilly and Company
$150
Genentech USA, Inc.
$123
Medtronic USA, Inc.
$122
Ipsen Biopharmaceuticals, Inc
$119
Pernix Therapeutics Holdings, Inc.
$112
Greenwich Biosciences, Inc.
$109
GRT US Holding, Inc.
$109
W. L. Gore & Associates, Inc.
$103
HARMONY BIOSCIENCES LLC
$103
Endo Pharmaceuticals Inc.
$92
Merck Sharp & Dohme LLC
$90
Zyla Life Sciences, Inc.
$79
Banner Life Sciences, LLC
$70
Boston Scientific Corporation
$68
Acorda Therapeutics, Inc
$64
Arbor Pharmaceuticals, Inc.
$62
Amneal Pharmaceuticals LLC
$61
BANNER LIFE SCIENCES, LLC
$60
TG Therapeutics, Inc.
$60
Adamas Pharmaceuticals, Inc.
$57
JAZZ PHARMACEUTICALS INC.
$52
Janssen Pharmaceuticals, Inc
$50
CSL Behring
$48
Grifols USA, LLC
$45
Horizon Therapeutics plc
$44
Takeda Pharmaceuticals U.S.A., Inc.
$42
Jazz Pharmaceuticals Inc.
$39
Sunovion Pharmaceuticals Inc.
$37
MITSUBISHI TANABE PHARMA AMERICA, INC.
$32
GENZYME CORPORATION
$32
Octapharma USA, Inc.
$32
ARGENX US, INC.
$32
Mallinckrodt LLC
$32
EISAI INC.
$31
Novocure Inc.
$30
Vertical Pharmaceuticals, LLC
$29
Horizon Pharma plc
$27
Merz North America, Inc.
$24
Mirum Pharmaceuticals, Inc.
$22
Akcea Therapeutics, Inc.
$22
Otsuka America Pharmaceutical, Inc.
$20
Catalyst Pharmaceuticals, Inc.
$20
CATALYST PHARMACEUTICALS, INC.
$19
Vanda Pharmaceuticals Inc.
$19
Neos Therapeutics, LP
$18
Novo Nordisk Inc
$18
IBSA Pharma Inc.
$17
Neurelis, Inc.
$15
Alnylam Pharmaceuticals Inc.
$15
US WorldMeds, LLC
$14
Amylyx Pharmaceuticals, Inc.
$14
GE HealthCare
$13
Bayer HealthCare Pharmaceuticals Inc.
$12
AstraZeneca Pharmaceuticals LP
$12
Impax Laboratories, Inc.
$12
Top 3 companies account for 48.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AGAMREE · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUSTEDO · AVONEX · Adzenys XR-ODT · Aimovig · Assure WCD · Austedo XR · BAFIERTAM · BELSOMRA · BOTOX · BOTOX - MIGRAINE · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Betaseron · Briviact · CAMBIA · CARDIOFORM Septal Occluder · COMIRNATY · CONTRAVE · COPAXONE · Cambia · Cholbam · DYSPORT · ELYXYB - CELECOXIB · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · Epidiolex · Eprontia · FYCOMPA · Fycompa · GOCOVRI · GRALISE · Gamunex-C · Gocovri · Gralise · HORIZANT · HYQVIA · Hetlioz · Hizentra · Horizant · INBRIJA · INGREZZA · KRYSTEXXA · KYNMOBI · LORZONE · LUMIZYME · LYRICA · LYVISPAH · Leqembi · MYOBLOC · NASCOBAL · NORTHERA · NO_PRODUCT · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONPATTRO · ONZETRA · ONZETRA XSAIL · ONZETRA Xsail · OXTELLAR XR · Oncology · Ongentys · PANZYGA · PAXLOVID · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · Qutenza · RADICAVA · RAYOS · RELYVRIO · REYVOW · RYTARY · Rystiggo · SILENOR · SPRIX · Soliris · Solitaire · TEGSEDI · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TREXIMET · TROKENDI XR · TYSABRI · Tirosint · Tosymra Sumatriptan Nasal Spray · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VIMOVO · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VYEPTI · VYVGART HYTRULO · Vyvanse · WATCHMAN Access System · WELIREG · Wakix · Wegovy · XEOMIN · XYWAV · ZAVZPRET · ZEMBRACE SYMTOUCH · ZEPBOUND · ZIPSOR · ZOMIG · ZONISADE · ZORVOLEX · Zembrace · Zembrace SymTouch Sumatriptan Injection · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (94%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for neurology in NY.
Geographic Context
Neurologists within 10 mi
73
Per 100K population
7.7
County median income
$71,175
Nearest hospital
UPSTATE NEW YORK VA HEALTHCARE SYSTEM (WESTERN NY VA HEALTHCARE SYSTEM)
2.5 mi
2.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Saikali is a mixed practice specialist, with above-average Medicare volume (top 8% in NY), with speaking/promotional industry engagement in the top 0% of NY peers, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Saikali experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Saikali performed 10,800 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Saikali receive payments from pharmaceutical companies?
Yes. Dr. Saikali received a total of $1,545,186 from 97 companies across 3,557 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Saikali's costs compare to other neurologists in Amherst?
Dr. Saikali's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Saikali) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Amherst
Browse neurologists in Amherst ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NY
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NY
Which NY neurologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology